HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma.

Abstract
DNA vaccination against HER-2/neu is an effective way to induce an immune response able to oppose the spontaneous development of mammary tumours occurring in HER-2/neu transgenic mice. In this study, we have evaluated the potential of Imiquimod and the analogue S-27609 as adjuvants of DNA vaccination against HER-2/neu in transgenic mice. The association of a DNA vaccine encoding a portion of rat HER2/neu with either Imiquimod or S-27609 was found to delay the development of spontaneous mammary tumours and to reduce their incidence, in comparison with DNA vaccination alone. Almost 80 or 40% of tumour-free mice were found at the end of measurement time in mice vaccinated and supplemented with Imiquimod or S-27609, respectively. The antitumour preventive effect was associated with increased antibody and cell-mediated immune responsiveness against HER-2/neu. In mice vaccinated and supplemented with Imiquimod, a small but significant increase of rat p185neu-specific cytotoxicity and of IFN-gamma and IL-2-producing CD8T cells, together with a reduction of IL-4-producing CD4T cells, and a switch from an IgG1 towards a IgG2a phenotype of anti-p185neu antibodies, suggested a TH1 polarization of the immune response. The immunoregulatory efficacy of S-27609 was lower than that observed for Imiquimod. These data highlight the potential of Imiquimod, and, to a lower extent, of S-27609, as immunological adjuvants of therapeutic DNA vaccines.
AuthorsA Smorlesi, F Papalini, F Orlando, A Donnini, F Re, M Provinciali
JournalGene therapy (Gene Ther) Vol. 12 Issue 17 Pg. 1324-32 (Sep 2005) ISSN: 0969-7128 [Print] England
PMID15944732 (Publication Type: Journal Article)
Chemical References
  • 4-amino-alpha,alpha,2-trimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol
  • Adjuvants, Immunologic
  • Aminoquinolines
  • Cancer Vaccines
  • Interleukin-2
  • Vaccines, DNA
  • Interleukin-10
  • Interferon-gamma
  • Imiquimod
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Adoptive Transfer
  • Aminoquinolines (administration & dosage)
  • Animals
  • Cancer Vaccines (administration & dosage)
  • Female
  • Genes, erbB-2
  • Genetic Therapy (methods)
  • Imiquimod
  • Interferon-gamma (immunology)
  • Interleukin-10 (immunology)
  • Interleukin-2 (immunology)
  • Mammary Neoplasms, Experimental (genetics, immunology, therapy)
  • Mice
  • Mice, Transgenic
  • Models, Animal
  • Vaccines, DNA (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: